<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38805163</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-2592</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical immunology</Title><ISOAbbreviation>J Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Fluoxetine Successfully Treats Intracranial Enterovirus E18 Infection in a Patient with CD79a Deficiency Arising from Segmental Uniparental Disomy of Chromosome 19.</ArticleTitle><Pagination><StartPage>137</StartPage><MedlinePgn>137</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10875-024-01740-7</ELocationID><Abstract><AbstractText>The pre BCR complex plays a crucial role in B cell production, and its successful expression marks the B cell differentiation from the pro-B to pre-B. The CD79a and CD79b mutations, encoding Igα and Igβ respectively, have been identified as the cause of autosomal recessive agammaglobulinemia (ARA). Here, we present a case of a patient with a homozygous CD79a mutation, exhibiting recurrent respiratory infections, diarrhea, growth and development delay, unique facial abnormalities and microcephaly, as well as neurological symptoms including tethered spinal cord, sacral canal cyst, and chronic enteroviral E18 meningitis. Complete blockade of the early B cell development in the bone marrow of the patient results in the absence of peripheral circulating mature B cells. Whole exome sequencing revealed a Loss of Heterozygosity (LOH) of approximately 19.20Mb containing CD79a on chromosome 19 in the patient. This is the first case of a homozygous CD79a mutation caused by segmental uniparental diploid (UPD). Another key outcome of this study is the effective management of long-term chronic enteroviral meningitis using a combination of intravenous immunoglobulin (IVIG) and fluoxetine. This approach offers compelling evidence of fluoxetine's utility in treating enteroviral meningitis, particularly in immunocompromised patients.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yu</LastName><ForeName>Lang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yishi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Medicine Diagnostic and Testing Center, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Jinxiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yulin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Haoru</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chenlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Wenli</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Yanjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology &amp; Immunology, Children's Hospital of Chongqing Medical University, No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing, 400014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology &amp; Immunology, Children's Hospital of Chongqing Medical University, No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing, 400014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Yuntao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology &amp; Immunology, Children's Hospital of Chongqing Medical University, No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing, 400014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China. zhaoxd530@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China. zhaoxd530@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology &amp; Immunology, Children's Hospital of Chongqing Medical University, No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing, 400014, China. zhaoxd530@aliyun.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Yunfei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China. anyf82@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China. anyf82@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology &amp; Immunology, Children's Hospital of Chongqing Medical University, No. 136, Zhongshan 2nd Road, Yuzhong District, Chongqing, 400014, China. anyf82@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NO.2024GGXM004</GrantID><Agency>Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau)</Agency><Country /></Grant><Grant><GrantID>82070135</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>2021YFC2700804</GrantID><Agency>National Key R&amp;D Program of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Immunol</MedlineTA><NlmUniqueID>8102137</NlmUniqueID><ISSNLinking>0271-9142</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>01K63SUP8D</RegistryNumber><NameOfSubstance UI="D005473">Fluoxetine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051925">CD79 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005473" MajorTopicYN="Y">Fluoxetine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024182" MajorTopicYN="Y">Uniparental Disomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002888" MajorTopicYN="Y">Chromosomes, Human, Pair 19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000361" MajorTopicYN="Y">Agammaglobulinemia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051925" MajorTopicYN="N">CD79 Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Agammaglobulinemia</Keyword><Keyword MajorTopicYN="N">CD79a mutation</Keyword><Keyword MajorTopicYN="N">Enteroviral meningitis</Keyword><Keyword MajorTopicYN="N">Fluoxetine</Keyword><Keyword MajorTopicYN="N">Uniparental disomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>28</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>28</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>28</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38805163</ArticleId><ArticleId IdType="doi">10.1007/s10875-024-01740-7</ArticleId><ArticleId IdType="pii">10.1007/s10875-024-01740-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tangye SG, Nguyen T, Deenick EK, Bryant VL, Ma CS. Inborn errors of human B cell development, differentiation, and function. J Exp Med. 2023;220(7):e20221105. https://doi.org/10.1084/jem.20221105 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20221105</ArticleId><ArticleId IdType="pubmed">37273190</ArticleId><ArticleId IdType="pmc">10242086</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchers F. Checkpoints that control B cell development. J Clin Invest. 2015;125(6):2203–10. https://doi.org/10.1172/JCI78083 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI78083</ArticleId><ArticleId IdType="pubmed">25938781</ArticleId><ArticleId IdType="pmc">4497745</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131(4):959–71. https://doi.org/10.1016/j.jaci.2013.01.046 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2013.01.046</ArticleId><ArticleId IdType="pubmed">23465663</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan D, Tergaonkar V. Unraveling B cell trajectories at single cell resolution. Trends Immunol. 2022;43(3):210–29. https://doi.org/10.1016/j.it.2022.01.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.01.003</ArticleId><ArticleId IdType="pubmed">35090788</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Seppänen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42(7):1473–507. https://doi.org/10.1007/s10875-022-01289-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-022-01289-3</ArticleId><ArticleId IdType="pubmed">35748970</ArticleId><ArticleId IdType="pmc">9244088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari S, Lougaris V, Caraffi S, Zuntini R, Yang J, Soresina A, Meini A, Cazzola G, Rossi C, Reth M, Plebani A. Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med. 2007;204(9):2047–51. https://doi.org/10.1084/jem.20070264 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20070264</ArticleId><ArticleId IdType="pubmed">17709424</ArticleId><ArticleId IdType="pmc">2118692</ArticleId></ArticleIdList></Reference><Reference><Citation>Conley ME, Dobbs AK, Quintana AM, Bosompem A, Wang YD, Coustan-Smith E, Smith AM, Perez EE, Murray PJ. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. J Exp Med. 2012;209(3):463–70. https://doi.org/10.1084/jem.20112533 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20112533</ArticleId><ArticleId IdType="pubmed">22351933</ArticleId><ArticleId IdType="pmc">3302225</ArticleId></ArticleIdList></Reference><Reference><Citation>Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, Coustan-Smith E, Howard V, Campana D. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227. https://doi.org/10.1146/annurev.immunol.021908.132649 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132649</ArticleId><ArticleId IdType="pubmed">19302039</ArticleId></ArticleIdList></Reference><Reference><Citation>Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley ME. Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest. 1999;104(8):1115–21. https://doi.org/10.1172/JCI7696 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI7696</ArticleId><ArticleId IdType="pubmed">10525050</ArticleId><ArticleId IdType="pmc">408581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Kanegane H, Sanal O, Tezcan I, Ersoy F, Futatani T, Miyawaki T. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am J Med Genet. 2002;108(4):333–6. https://doi.org/10.1002/ajmg.10296 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.10296</ArticleId><ArticleId IdType="pubmed">11920841</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili A, Plebani A, Vitali M, Abolhassani H, Lougaris V, Mirminachi B, Rezaei N, Aghamohammadi A. Autosomal recessive agammaglobulinemia: a novel non-sense mutation in CD79a. J Clin Immunol. 2014;34(2):138–41. https://doi.org/10.1007/s10875-014-9989-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-014-9989-3</ArticleId><ArticleId IdType="pubmed">24481606</ArticleId></ArticleIdList></Reference><Reference><Citation>Langereis JD, Henriet SS, Kuipers S, Weemaes CMR, van der Burg M, de Jonge MI, van der Flier M. IgM Augments Complement bactericidal activity with serum from a patient with a novel CD79a mutation. J Clin Immunol. 2018;38(2):185–92. https://doi.org/10.1007/s10875-017-0474-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-017-0474-7</ArticleId><ArticleId IdType="pubmed">29335801</ArticleId><ArticleId IdType="pmc">5840230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Ali M, Kechout N, Mekki N, Yang J, Chan KW, Barakat A, Aadam Z, Gamara J, Gargouri L, Largueche B, BelHadj-Hmida N, Nedri A, Ameur HB, Mellouli F, Boukari R, Bejaoui M, Bousfiha A, Ben-Mustapha I, Lau YL, Barbouche MR. Genetic approaches for definitive diagnosis of agammaglobulinemia in consanguineous families. J Clin Immunol. 2020;40(1):96–104. https://doi.org/10.1007/s10875-019-00706-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-019-00706-4</ArticleId><ArticleId IdType="pubmed">31696364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Chen X, Yang Q, Tang W, Jia Y, Zhou L, An Y, Zhang Z, Tang X, Zhao X. E1021K homozygous mutation in PIK3CD leads to activated PI3K-Delta Syndrome 1. J Clin Immunol. 2020;40(2):378–87. https://doi.org/10.1007/s10875-020-00749-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00749-y</ArticleId><ArticleId IdType="pubmed">31953711</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Sun Y, Yu L, Chen R, Gan R, Qiu L, Sun G, Chen J, Zhou L, Ding Y, Du H, Shu Z, Zhang Z, Tang X, Chen Y, Zhao X, Zhao Q, An Y. Multiple immune defects in two patients with novel DOCK2 mutations result in recurrent multiple infection including live attenuated virus vaccine. J Clin Immunol. 2023;43(6):1193–207. https://doi.org/10.1007/s10875-023-01466-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-023-01466-y</ArticleId><ArticleId IdType="pubmed">36947335</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Li W, Lv G, Sun G, Yang L, Chen J, Zhou L, Ding Y, Zhang Z, Tang X, An Y, Zhao X. De novo somatic mosaicism of CYBB caused by intronic LINE-1 element insertion resulting in chronic granulomatous disease. J Clin Immunol. 2023;43(1):88–100. https://doi.org/10.1007/s10875-022-01347-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-022-01347-w</ArticleId><ArticleId IdType="pubmed">35997928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W, Zhang Y, Luo C, Zhou L, Zhang Z, Tang X, Zhao X, An Y. Clinical application of metagenomic next-generation sequencing for suspected infections in patients with primary immunodeficiency disease. Front Immunol. 2021;13(12):696403. https://doi.org/10.3389/fimmu.2021.696403 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.696403</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331–60. https://doi.org/10.1146/annurev.iy.11.040193.001555 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.iy.11.040193.001555</ArticleId><ArticleId IdType="pubmed">8476565</ArticleId></ArticleIdList></Reference><Reference><Citation>Gofshteyn J, Cárdenas AM, Bearden D. Treatment of chronic enterovirus encephalitis with fluoxetine in a patient with X-Linked Agammaglobulinemia. Pediatr Neurol. 2016;64:94–8. https://doi.org/10.1016/j.pediatrneurol.2016.06.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2016.06.014</ArticleId><ArticleId IdType="pubmed">27640319</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeersch G, Laenen L, Lens G, van der Elst KCM, Thal DR, Jentjens S, Demaerel P, Van Nieuwenhuyse T, Wollants E, Boeckx N, Verhaert N, Dubois B, Kuppeveld FJM, Woei-A-Jin FJSH. Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis. Eur J Neurol. 2022;29(10):3117–23. https://doi.org/10.1111/ene.15478 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15478</ArticleId><ArticleId IdType="pubmed">35763378</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones TPW, Buckland M, Breuer J, Lowe DM. Viral infection in primary antibody deficiency syndromes. Rev Med Virol. 2019;29(4):e2049. https://doi.org/10.1002/rmv.2049 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2049</ArticleId><ArticleId IdType="pubmed">31016825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearden D, Collett M, Quan PL, Costa-Carvalho BT, Sullivan KE. Enteroviruses in X-Linked agammaglobulinemia: update on epidemiology and therapy. J Allergy Clin Immunol Pract. 2016;4(6):1059–65. https://doi.org/10.1016/j.jaip.2015.12.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2015.12.015</ArticleId><ArticleId IdType="pubmed">26883540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Manganaro R, Zonsics B, Strating JRPM, El Kazzi P, Lorenzo Lopez M, Ulferts R, van Hoey C, Maté MJ, Langer T, Coutard B, Brancale A, van Kuppeveld FJM. Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner. ACS Infect Dis. 2019;5(9):1609–23. https://doi.org/10.1021/acsinfecdis.9b00179 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.9b00179</ArticleId><ArticleId IdType="pubmed">31305993</ArticleId><ArticleId IdType="pmc">6747591</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurdiss DL, El Kazzi P, Bauer L, Papageorgiou N, Ferron FP, Donselaar T, van Vliet ALW, Shamorkina TM, Snijder J, Canard B, Decroly E, Brancale A, Zeev-Ben-Mordehai T, Förster F, van Kuppeveld FJM, Coutard B (2022) Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex. Sci Adv 8(1):eabj7615. https://doi.org/10.1126/sciadv.abj7615</Citation></Reference><Reference><Citation>Tyler KL. Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis. JAMA Neurol. 2015;72(5):493–4. https://doi.org/10.1001/jamaneurol.2014.4625 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.4625</ArticleId><ArticleId IdType="pubmed">25775436</ArticleId><ArticleId IdType="pmc">5086417</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla S, Jindal AK, Arora K, Tyagi R, Dhaliwal M, Rawat A. T Cell Abnormalities in X-Linked agammaglobulinaemia: an updated review. Clin Rev Allergy Immunol. 2023;65(1):31–42. https://doi.org/10.1007/s12016-022-08949-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08949-7</ArticleId><ArticleId IdType="pubmed">35708830</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, Yel L, Sullivan KE. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(6):627–32. https://doi.org/10.1007/s10875-014-0056-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-014-0056-x</ArticleId><ArticleId IdType="pubmed">24909997</ArticleId><ArticleId IdType="pmc">4157090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>